Malaria vaccines

References

• World Health Organization. World Malaria Report 2021.
   Google Scholar
• White NJ, Pukrittayakamee S, Hien TT, et al. Malaria. Lancet. 2014;383:723–735.
   PubMed Web of Science ®Google Scholar
• Sinka ME, Bangs MJ, Manguin S, et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic précis. Parasites Vectors. 2010;3:117.
   PubMed Web of Science ®Google Scholar
• Bate, Roger. The rise, fall, rise, and imminent fall of DDT. American Enterprise Institute. 2007. [cited 2023 Jan 20]. Available from: https://www.aei.org/research-products/report/the-rise-fall-rise-and-imminent-fall-of-ddt/
   Google Scholar
• Rosenberg R, Wirtz RA, Schneider I, et al. An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans R Soc Trop Med Hyg. 1990;84:209–212.
   PubMed Web of Science ®Google Scholar
• Ponnudurai T, Lensen AHW, van Gemert GJA, et al. Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans R Soc Trop Med Hyg. 1991;85:175–180.
   PubMed Web of Science ®Google Scholar
• Mota MM, Hafalla JCR, Rodriguez A. Migration through host cells activates Plasmodium sporozoites for infection. Nat Med. 2002;8:1318–1322.
   PubMed Web of Science ®Google Scholar
• Mota MM, Pradel G, Vanderberg JP, et al. Migration of Plasmodium Sporozoites through cells before infection. Science. 2001;291:141–144.
   PubMed Web of Science ®Google Scholar
• Moorthy VS, Good MF, Hill AV. Malaria vaccine developments. Lancet. 2004;363:150–156.
   PubMed Web of Science ®Google Scholar
• Venugopal K, Hentzschel F, Valkiūnas G, et al. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat Rev Microbiol. 2020;18:177–189.
   PubMed Web of Science ®Google Scholar
• Duffy PE. Current approaches to malaria vaccines. Curr Opin Microbiol. 2022;70:102227.
   PubMed Web of Science ®Google Scholar
• Arcà B, Lombardo F, Struchiner CJ, et al. Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species. BMC Genomics. 2017;18:153.
   PubMed Web of Science ®Google Scholar
• Yang ASP, O’Neill MT, Jennison C, et al. Cell traversal activity is important for Plasmodium falciparum liver infection in humanized mice. Cell Rep. 2017;18:3105–3116.
   PubMed Web of Science ®Google Scholar
• Yale University.Mosquito saliva protein malaria vaccine. US2018000911. 2018.
   Google Scholar
• Rathore D, Sacci JB, de la Vega P, et al. Binding and invasion of liver cells by Plasmodium falciparum sporozoites. J Biol Chem. 2002;277:7092–7098.
   PubMed Web of Science ®Google Scholar
• Ménard R, Sultan AA, Cortes C, et al. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature. 1997;385:336–340.
   PubMed Web of Science ®Google Scholar
• Sidjanski SP, Vanderberg JP, Sinnis P. Anopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum. Mol Biochem Parasitol. 1997;90:33–41.
   PubMed Web of Science ®Google Scholar
• Cerami C, Frevert U, Sinnis P, et al. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of plasmodium falciparum sporozoites. Cell. 1992;70:1021–1033.
   PubMed Web of Science ®Google Scholar
• Frevert U, Sinnis P, Cerami C, et al. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med. 1993;177:1287–1298.
   PubMed Web of Science ®Google Scholar
• Porter MD, Nicki J, Pool CD, et al. Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint. Clin Vaccine Immunol. 2013;20:803–810.
   PubMedGoogle Scholar
• Oyen D, Torres JL, Wille-Reece U, et al. Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA. 2017;114. 10.1073/pnas.1715812114.
   PubMed Web of Science ®Google Scholar
• Heide J, Vaughan KC, Sette A, et al. Comprehensive review of human Plasmodium falciparum-specific CD8+ T cell epitopes. Front Immunol. 2019;10:397.
   PubMed Web of Science ®Google Scholar
• Heppnerjr D, Kester K, Ockenhouse C, et al. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine. 2005. 23 : 2243–2250.
   PubMed Web of Science ®Google Scholar
• Cohen J, Nussenzweig V, Vekemans J, et al. From the circumsporozoite protein to the RTS,S/AS candidate vaccine. Hum Vaccines. 2010;6:90–96.
   PubMed Web of Science ®Google Scholar
• Efficacy and safety of RTS,S/AS01. malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31–45.
   PubMedGoogle Scholar
• Didierlaurent AM, Laupèze B, Di Pasquale A, et al. Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Rev Vaccines. 2017;16:55–63.
   PubMed Web of Science ®Google Scholar
• Government US. Soluble recombinant Plasmodium falciparum Circumsporozoite protein, use in vaccines, methods of making and uses thereof. US2016038580. 2016.
   Google Scholar
• Macfarlane Burnet Institute for Medical Res and Public Health Limited.Immunogenic compositions. WO2022027107. 2022.
   Google Scholar
• Inst. Res. Biomedicine; Seattle Childrens Hospital D/B/a Seattle Childrens Res Institute; Schweizerisches Tropen Und Public Health Inst. Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to. US2020093909. 2020.
   Google Scholar
• Wang LT, Pereira LS, Flores-Garcia Y, et al. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity. 2020;53:733–744.e8.
   PubMed Web of Science ®Google Scholar
• Hospital for Sick Children; Deutsches Krebsforschungszentrum Dkfz. Malaria vaccine composition and method. WO2019023812. 2019.
   Google Scholar
• Univ. Oxford Innovation Ltd. Vaccines. US2022168409. 2022.
   Google Scholar
• Vlp Therapeutics Llc. Malaria vaccine. US2019351041. 2019.
   Google Scholar
• Curevac. Ag. RNA for malaria vaccines. US2022040281. 2022.
   Google Scholar
• Pasteur Institut; Centre Nat Rech Scient. Recombinant measles virus expressing proteins of a plasmodium parasite and their applications. WO2019224607. 2019.
   Google Scholar
• Janssen Vaccines & Prevention Bv. An improved adenovirus based malaria vaccine encoding and displaying a malaria antigen. US2019083597. 2019.
   Google Scholar
• Univ. Rockefeller. Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes. EP3412306. 2018.
   Google Scholar
• Singh SK, Plieskatt J, Chourasia BK, et al. The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable. J Biol Chem. 2020;295:403–414.
   PubMed Web of Science ®Google Scholar
• Path; Sumitomo Dainippon Pharma Co Ltd. Pre-erythrocytic malaria vaccines. WO2022003999. 2022.
   Google Scholar
• Lehmann C, Heitmann A, Mishra S, et al. A cysteine protease inhibitor of plasmodium berghei is essential for exo-erythrocytic development. PLoS Pathog. 2014;10:e1004336. Bogyo M, editor.
   PubMed Web of Science ®Google Scholar
• Pihlajamaa T, Kajander T, Knuuti J, et al. Structure of Plasmodium falciparum TRAP (thrombospondin-related anonymous protein) A domain highlights distinct features in apicomplexan von Willebrand factor A homologues. Biochem J. 2013;450:469–476.
   PubMed Web of Science ®Google Scholar
• Pasteur Institut. Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host. US2021187089. 2021.
   Google Scholar
• Longley RJ, Salman AM, Cottingham MG, et al. Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates. Sci Rep. 2015;5:11820.
   PubMed Web of Science ®Google Scholar
• Sharma A, Yogavel M, Akhouri RR, et al. Crystal structure of soluble domain of malaria sporozoite protein UIS3 in complex with lipid. J Biol Chem. 2008;283:24077–24088.
   PubMedGoogle Scholar
• Ishino T, Yano K, Chinzei Y, et al. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2004;2:e4. Gary Ward, editor.
   PubMed Web of Science ®Google Scholar
• Ewer KJ, Sierra-Davidson K, Salman AM, et al. Progress with viral vectored malaria vaccines: a multi-stage approach involving “unnatural immunity.” Vaccine. 2015;33:7444–7451.
   PubMed Web of Science ®Google Scholar
• Isis Innovation; Acad. Ziekenhuis Leiden. Malaria vaccination. US2016250312. 2016.
   Google Scholar
• The Administrators of the Tulane Educational Fund; Univ Louisiana State. Viral-vectored vaccine for malaria. US2021324416. 2021.
   Google Scholar
• Nussenzweig RS, Vanderberg J, Most H, et al. Protective immunity produced by the injection of X-irradiated sporozoites of plasmodium berghei. Nature. 1967;216:160–162.
   PubMed Web of Science ®Google Scholar
• Clyde DF, Most H, McCARTHY VC, et al. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci. 1973;266:169–177.
   PubMed Web of Science ®Google Scholar
• Rieckmann KH, Carson PE, Beaudoin RL, et al. Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1974;68:258–259.
   PubMed Web of Science ®Google Scholar
• Sanaria Inc. Purified plasmodium and vaccine compositions. US2016175417. 2016.
   Google Scholar
• Sanaria Inc; Academisch Ziekenhuis Leiden; Stichting Katholieke Universteit. Genetic attenuation of plasmodium by B9 gene disruption. US2017252419. 2017.
   Google Scholar
• van Schaijk BCL, Ploemen IHJ, Annoura T, et al. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites. eLife. 2014;3:e03582.
   PubMed Web of Science ®Google Scholar
• Annoura T, Schaijk BCL, Ploemen IHJ, et al. Two Plasmodium 6‐Cys family‐related proteins have distinct and critical roles in liver‐stage development. FASEB J. 2014;28:2158–2170.
   PubMed Web of Science ®Google Scholar
• La Jolla Pharma Co; St Georges Hospital Medical School DBa St Georges Univ of London. Methods of inducing anti-malarial immune responses and compositions related thereto. WO2018175633. 2018.
   Google Scholar
• Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783–788.
   PubMed Web of Science ®Google Scholar
• Spottiswoode N, Duffy PE, Drakesmith H. Iron, anemia and hepcidin in malaria. Front Pharmacol. 2014;5. 10.3389/fphar.2014.00125
   PubMed Web of Science ®Google Scholar
• Aniweh Y, Gao X, Hao P, et al. P. falciparum RH5-Basigin interaction induces changes in the cytoskeleton of the host RBC. Cell Microbiol. 2017;19:e12747.
   Web of Science ®Google Scholar
• Wright KE, Hjerrild KA, Bartlett J, et al. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature. 2014;515:427–430.
   PubMed Web of Science ®Google Scholar
• Univ Oxford Innovation Ltd. Treatment and prevention of malaria. US2017209558. 2017.
   Google Scholar
• Nagaoka H, Kanoi BN, Ntege EH, et al. Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A. Sci Rep. 2020;10:6573.
   PubMedGoogle Scholar
• Walter & Eliza Hall Inst Medical Res; Expression Biotechnologies. Malaria vaccine and methods for producing same. US2021268093. 2021.
   Google Scholar
• Sumitomo Dainippon Pharma Co Ltd; Univ. Nat. Corp. Ehime Univ. Malarias vaccine. US2019343943. 2019.
   Google Scholar
• Michelow IC, Park S, Tsai S-W, et al. A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies. J Exp Med. 2021;218:e20200170.
   PubMed Web of Science ®Google Scholar
• Rhode Island Hospital. Malaria antigens on the surface of erythrocytes and merozoites and protective antibodies. US2022072115. 2022.
   Google Scholar
• Rowe JA. Rosetting. In: Hommel M, Kremsner PG, editors. Encyclopedia of malaria. New York: Springer New York; 2014. p. 1–12.
   Google Scholar
• Vigan-Womas I, Guillotte M, Juillerat A, et al. Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting. PLoS Pathog. 2012;8:e1002781. Rowe JA, editor.
   PubMed Web of Science ®Google Scholar
• Quintana MDP, Ch’ng J-H, Moll K, et al. Antibodies in children with malaria to PfEMP1. RIFIN and SURFIN expressed at the Plasmodium falciparum parasitized red blood cell surface. Sci Rep. 2018;8:3262.
   PubMedGoogle Scholar
• Goel S, Palmkvist M, Moll K, et al. RIFINs are adhesins implicated in severe Plasmodium falciparum malaria. Nat Med. 2015;21:314–317.
   PubMed Web of Science ®Google Scholar
• McQuaid F, Rowe JA. Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting. Parasitology. 2020;147:1–11.
   PubMed Web of Science ®Google Scholar
• Inst. for Res. in Biomedicine. Novel vaccines in prevention and treatment of malaria. WO2016207408. 2016.
   Google Scholar
• Mundwiler-Pachlatko E, Beck H-P. Maurer’s clefts, the enigma of Plasmodium falciparum. Proc Natl Acad Sci USA. 2013;110:19987–19994.
   PubMed Web of Science ®Google Scholar
• Rhode Island Hospital; Seattle Biomedical Res Inst. Vaccine for falciparum malaria. US2017258884. 2017.
   Google Scholar
• Akter J, Khoury DS, Aogo R, et al. Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells. PLoS Pathog. 2019;15:e1007599. Blackman MJ, editor.
   PubMed Web of Science ®Google Scholar
• Pombo DJ, Lawrence G, Hirunpetcharat C, et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 2002;360:610–617.
   PubMed Web of Science ®Google Scholar
• Pinzon-Charry A, McPhun V, Kienzle V, et al. Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice. J Clin Invest. 2010;120:2967–2978.
   PubMed Web of Science ®Google Scholar
• Univ. Griffith. Vaccine comprising drug and parasite administration. US2019224293. 2019.
   Google Scholar
• Low LM, Ssemaganda A, Liu XQ, et al. Controlled infection immunization using delayed death drug treatment elicits protective immune responses to blood-stage malaria parasites. Infect Immun. 2019;87:e00587–18. Adams JH, editor
   PubMed Web of Science ®Google Scholar
• Univ. Griffith; Univ. Queensland. Liposomal malaria vaccine. NL2016067. 2017.
   Google Scholar
• Stc. Unm; Leidos Inc. Malaria vaccine. US2016228525. 2016.
   Google Scholar
• Carter R. Transmission blocking malaria vaccines. Vaccine. 2001;19:2309–2314.
   PubMed Web of Science ®Google Scholar
• van Dijk MR, Janse CJ, Thompson J, et al. A central role for P48/45 in malaria parasite male gamete fertility. Cell. 2001;104:153–164.
   PubMed Web of Science ®Google Scholar
• Singh SK, Thrane S, Chourasia BK, et al. Pfs230 and Pfs48/45 fusion proteins elicit strong transmission-blocking antibody responses against Plasmodium falciparum. Front Immunol. 2019;10:1256.
   PubMed Web of Science ®Google Scholar
• Statens Seruminstitut; Univ. Copenhagen. Multivalent malaria transmission-blocking vaccines. WO2020201191. 2020.
   Google Scholar
• Miura K, Deng B, Tullo G, et al. Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays. PLoS One. 2013;8:e57909. Diemert DJ, editor.
   PubMed Web of Science ®Google Scholar
• Barr PJ, Green KM, Gibson HL, et al. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J Exp Med. 1991;174:1203–1208.
   PubMed Web of Science ®Google Scholar
• Hu X, Chen Z, Xiong K, et al. Vi capsular polysaccharide: synthesis, virulence, and application. Crit Rev Microbiol. 2017;43:440–452.
   PubMed Web of Science ®Google Scholar
• US Health; Int. Vaccine Inst. Bivalent immunogenic conjugate for malaria and typhoid. WO2017189448. 2017.
   Google Scholar
• Sasaki H, Sekiguchi H, Sugiyama M, et al. Plasmodium berghei Cap93, a novel oocyst capsule-associated protein, plays a role in sporozoite development. Parasites Vectors. 2017;10:399.
   PubMed Web of Science ®Google Scholar
• Hokusan Kk; Aist; School Juridical Person the Kitasato Inst. Malaria transmission blocking vaccine. US2021292382. 2021.
   Google Scholar
• Frauhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung EV. Three component-multistage malaria vaccine. US2017252420. 2017.
   Google Scholar
• Remarque EJ, Faber BW, Kocken CHM, et al. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immun. 2008;76:2660–2670.
   PubMed Web of Science ®Google Scholar
• Camris Int. Inc.Novel antigen for use in malaria vaccine. WO2017142843. 2017.
   Google Scholar
• Univ. Oxford Innovation Ltd; Fund Oswaldo Cruz– Fiocruz. Vaccine immunogens. WO2020229805. 2020.
   Google Scholar
• Tartaglia J, Perkus ME, Taylor J, et al. NYVAC: a highly attenuated strain of vaccinia virus. Virology. 1992;188:217–232.
   PubMed Web of Science ®Google Scholar
• The Government of the US Secretary of the Army. Nyvac-based plasmodium malaria vaccine. US2020147196. 2020.
   Google Scholar
• Core Technologies Inc. V. Poxvirus-plasmodium recombinants, compositions containing such recombinants, uses thereof, and methods of making and using same. EP3089756. 2016.
   Google Scholar
• Battle KE, Lucas TCD, Nguyen M, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study. Lancet. 2019;394:332–343.
   PubMed Web of Science ®Google Scholar
• Sulyok Z, Fendel R, Eder B, et al. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat Commun. 2021;12:2518.
   PubMed Web of Science ®Google Scholar